MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene ...
Researchers have discovered novel biomarkers that could allow doctors to detect endometriosis in its earliest stages through ...
The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
According to research from a team at the University of Utah Health and the University of Nevada, Reno School of Medicine, ...
Preliminary 2025 thyroid testing revenue grew 21% over prior yearInitial 2026 guidance of 16% growth in thyroid testing revenue All preferred ...
• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 ...
Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...
Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...
Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback